Molecular and cellular mechanisms of bone morphogenetic proteins and activins in the skin: Potential benefits for wound healing

Archives of Dermatological Research

Volumn 305, Issue 7, 2013, Pages 557-569

  Moura, J ^a   Da Silva, L ^a,b   Cruz, M T ^a,c   Carvalho, E ^a,d  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b UNIVERSITY OF COIMBRA   (Portugal)

^c UNIVERSITY OF COIMBRA   (Portugal)

^d The Portuguese Diabetes Association (APDP)   (Portugal)

Author keywords

Activins; Bone morphogenetic proteins; Inflammation; Intracellular signaling pathways; Skin; Wound healing

Indexed keywords

ACTIVIN; ACTIVIN RECEPTOR LIKE KINASE 1; ACTIVIN RECEPTOR LIKE KINASE 2; BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 6; BONE MORPHOGENETIC PROTEIN RECEPTOR 1A; BONE MORPHOGENETIC PROTEIN RECEPTOR 1B; COLLAGEN; NEUROPEPTIDE; SMAD PROTEIN; SMAD1 PROTEIN; SMAD5 PROTEIN; SMAD8 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ANGIOGENESIS; BONE REGENERATION; CARTILAGE; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; DIABETIC FOOT; ENDOTHELIUM CELL; EPITHELIZATION; FIBROBLAST; GRANULATION TISSUE; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; INFLAMMATION; MOLECULAR MECHANICS; MORPHOGENESIS; PHYLOGENY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REVIEW; SCAR FORMATION; SKIN INJURY; SKIN ULCER; WOUND HEALING;

ACTIVINS; ANIMALS; BONE MORPHOGENETIC PROTEINS; CELL DIFFERENTIATION; DIABETIC FOOT; HUMANS; REGENERATION; SIGNAL TRANSDUCTION; SKIN; WOUND HEALING;

EID: 84883240109     PISSN: 03403696     EISSN: 1432069X     Source Type: Journal    
DOI: 10.1007/s00403-013-1381-2     Document Type: Review

References (132)

1. Acosta JB, del Barco DG, Vera DC, Savigne W, Lopez-Saura P, Guillen Nieto G, Schultz GS (2008) The pro-inflammatory environment in recalcitrant diabetic foot wounds. Int Wound J 5(4):530-539
2. Ai X, Cappuzzello J, Hall AK (1999) Activin and bone morphogenetic proteins induce calcitonin gene-related peptide in embryonic sensory neurons in vitro. Mol Cell Neurosci 14(6):506-518
3. Al-Wahbi AM (2010) Impact of a diabetic foot care education program on lower limb amputation rate. Vasc Health Risk Manag 6:923-934
4. Anitha M, Shahnavaz N, Qayed E, Joseph I, Gossrau G, Mwangi S, Sitaraman SV, Greene JG, Srinivasan S (2010) BMP2 promotes differentiation of nitrergic and catecholaminergic enteric neurons through a Smad1-dependent pathway. Am J Physiol Gastrointest Liver Physiol 298(3):G375-G383
5. Antsiferova M, Klatte JE, Bodo E, Paus R, Jorcano JL, Matzuk MM, Werner S, Kogel H (2009) Keratinocyte-derived follistatin regulates epidermal homeostasis and wound repair. Lab Invest 89(2):131-141
6. Attisano L, Wrana JL (2002) Signal transduction by the TGF-beta superfamily. Science 296(5573):1646-1647
7. Au K, Ehrlich HP (2010) When the Smad signaling pathway is impaired, fibroblasts advance open wound contraction. Exp Mol Pathol 89(3):236-240
8. Bamberger C, Scharer A, Antsiferova M, Tychsen B, Pankow S, Muller M, Rulicke T, Paus R, Werner S (2005) Activin controls skin morphogenesis and wound repair predominantly via stromal cells and in a concentration-dependent manner via keratinocytes. Am J Pathol 167(3):733-747
9. Bandyopadhyay A, Yadav PS, Prashar P (2013) BMP signaling in development and diseases: A pharmacological perspective. Biochem Pharmacol 85(7):857-864
10. Beer HD, Gassmann MG, Munz B, Steiling H, Engelhardt F, Bleuel K, Werner S (2000) Expression and function of keratinocyte growth factor and activin in skin morphogenesis and cutaneous wound repair. J Investig Dermatol Symp Proc 5(1):34-39
11. Berlanga-Acosta J (2011) Diabetic lower extremity wounds: the rationale for growth factors-based infiltration treatment. Int Wound J 8(6):612-620
12. Bogdanski P, Pupek-Musialik D, Dytfeld J, Jagodzinski PP, Jablecka A, Kujawa A, Musialik K (2007) Influence of insulin therapy on expression of chemokine receptor CCR5 and selected inflammatory markers in patients with type 2 diabetes mellitus. Int J Clin Pharmacol Ther 45(10):563-567
13. Botchkarev VA (2003) Bone morphogenetic proteins and their antagonists in skin and hair follicle biology. J Invest Dermatol 120(1):36-47
14. Botchkarev VA, Sharov AA (2004) BMP signaling in the control of skin development and hair follicle growth. Differ Res Biol Divers 72(9-10):512-526
15. Boulais N, Misery L (2008) The epidermis: a sensory tissue. Eur J Dermatol 18(2):119-127
16. Bressan M, Davis P, Timmer J, Herzlinger D, Mikawa T (2009) Notochord-derived BMP antagonists inhibit endothelial cell generation and network formation. Dev Biol 326(1):101-111
17. Cassetta L, Cassol E, Poli G (2011) Macrophage polarization in health and disease. Sci World J 11:2391-2402
18. Chang H, Brown CW, Matzuk MM (2002) Genetic analysis of the mammalian transforming growth factor-beta superfamily. Endocr Rev 23(6):787-823
19. Cruise BA, Xu P, Hall AK (2004) Wounds increase activin in skin and a vasoactive neuropeptide in sensory ganglia. Dev Biol 271(1):1-10
20. Cunha SI, Pardali E, Thorikay M, Anderberg C, Hawinkels L, Goumans MJ, Seehra J, Heldin CH, ten Dijke P, Pietras K (2010) Genetic and pharmacological targeting of activin receptor-like kinase 1 impairs tumor growth and angiogenesis. J Exp Med 207(1):85-100
21. da Silva L, Carvalho E, Cruz MT (2010) Role of neuropeptides in skin inflammation and its involvement in diabetic wound healing. Expert Opin Biol Ther 10(10):1427-1439. doi: 10.1517/14712598.2010.515207
22. Dani C (2013) Activins in adipogenesis and obesity. Int J Obes (Lond) 37(2):163-166
23. David L, Mallet C, Mazerbourg S, Feige JJ, Bailly S (2007) Identification of BMP9 and BMP10 as functional activators of the orphan activin receptor-like kinase 1 (ALK1) in endothelial cells. Blood 109(5):1953-1961
24. David L, Mallet C, Vailhe B, Lamouille S, Feige JJ, Bailly S (2007) Activin receptor-like kinase 1 inhibits human microvascular endothelial cell migration: potential roles for JNK and ERK. J Cell Physiol 213(2):484-489
25. Davis PJ (2009) The double-edged sword of the immune system-a force for good or evil in the wound? Int Wound J 6(4):241-245
26. de Kretser DM, O'Hehir RE, Hardy CL, Hedger MP (2012) The roles of activin A and its binding protein, follistatin, in inflammation and tissue repair. Mol Cell Endocrinol 359(1-2):101-106
27. Derynck R (1994) TGF-beta-receptor-mediated signaling. Trends Biochem Sci 19(12):548-553
28. Dickinson S, Hancock DP, Petocz P, Ceriello A, Brand-Miller J (2008) High-glycemic index carbohydrate increases nuclear factor-kappaB activation in mononuclear cells of young, lean healthy subjects. Am J Clin Nutr 87(5):1188-1193
29. Eming SA, Krieg T, Davidson JM (2007) Inflammation in wound repair: molecular and cellular mechanisms. J Invest Dermatol 127(3):514-525
30. Endo D, Kogure K, Hasegawa Y, Maku-uchi M, Kojima I (2004) Activin A augments vascular endothelial growth factor activity in promoting branching tubulogenesis in hepatic sinusoidal endothelial cells. J Hepatol 40(3):399-404
31. Fessing MY, Atoyan R, Shander B, Mardaryev AN, Botchkarev VV Jr, Poterlowicz K, Peng Y, Efimova T, Botchkarev VA (2010) BMP signaling induces cell-type-specific changes in gene expression programs of human keratinocytes and fibroblasts. J Invest Dermatol 130(2):398-404
32. Freinkel RK, Woodley D (2001) The biology of the skin. Parthenon Pub. Group, New York
33. Fuchs E (2007) Scratching the surface of skin development. Nature 445(7130):834-842
34. Fumagalli M, Musso T, Vermi W, Scutera S, Daniele R, Alotto D, Cambieri I, Ostorero A, Gentili F, Caposio P, Zucca M, Sozzani S, Stella M, Castagnoli C (2007) Imbalance between activin A and follistatin drives postburn hypertrophic scar formation in human skin. Exp Dermatol 16(7):600-610
35. Funaba M, Ikeda T, Murakami M, Ogawa K, Abe M (2005) Up-regulation of mouse mast cell protease-6 gene by transforming growth factor-beta and activin in mast cell progenitors. Cell Signal 17(1):121-128
36. Funaba M, Ikeda T, Murakami M, Ogawa K, Tsuchida K, Sugino H, Abe M (2003) Transcriptional activation of mouse mast cell Protease-7 by activin and transforming growth factor-beta is inhibited by microphthalmia-associated transcription factor. J Biol Chem 278(52):52032-52041
37. Funaba M, Ikeda T, Ogawa K, Murakami M, Abe M (2003) Role of activin A in murine mast cells: modulation of cell growth, differentiation, and migration. J Leukoc Biol 73(6):793-801
38. Galiano RD, Tepper OM, Pelo CR, Bhatt KA, Callaghan M, Bastidas N, Bunting S, Steinmetz HG, Gurtner GC (2004) Topical vascular endothelial growth factor accelerates diabetic wound healing through increased angiogenesis and by mobilizing and recruiting bone marrow-derived cells. Am J Pathol 164(6):1935-1947
39. Game FL, Hinchliffe RJ, Apelqvist J, Armstrong DG, Bakker K, Hartemann A, Londahl M, Price PE, Jeffcoate WJ (2012) A systematic review of interventions to enhance the healing of chronic ulcers of the foot in diabetes. Diabetes/Metab Res Rev 28(Suppl 1):119-141
40. Ge J, Wang Y, Feng Y, Liu H, Cui X, Chen F, Tai G, Liu Z (2009) Direct effects of activin A on the activation of mouse macrophage RAW264.7 cells. Cell Mol Immunol 6(2):129-133
41. Gillitzer R, Goebeler M (2001) Chemokines in cutaneous wound healing. J Leukoc Biol 69(4):513-521
42. Gold LI, Sung JJ, Siebert JW, Longaker MT (1997) Type I (RI) and type II (RII) receptors for transforming growth factor-beta isoforms are expressed subsequent to transforming growth factor-beta ligands during excisional wound repair. Am J Pathol 150(1):209-222
43. Greenhalgh DG (1998) The role of apoptosis in wound healing. Int J Biochem Cell Biol 30(9):1019-1030
44. Gurtner GC, Werner S, Barrandon Y, Longaker MT (2008) Wound repair and regeneration. Nature 453(7193):314-321
45. Hall AK, Dinsio KJ, Cappuzzello J (2001) Skin cell induction of calcitonin gene-related peptide in embryonic sensory neurons in vitro involves activin. Dev Biol 229(2):263-270
46. Hayashi Y, Maeshima K, Goto F, Kojima I (2007) Activin A as a critical mediator of capillary formation: interaction with the fibroblast growth factor action. Endocr J 54(2):311-318
47. Heinke J, Wehofsits L, Zhou Q, Zoeller C, Baar KM, Helbing T, Laib A, Augustin H, Bode C, Patterson C, Moser M (2008) BMPER is an endothelial cell regulator and controls bone morphogenetic protein-4-dependent angiogenesis. Circ Res 103(8):804-812
48. Hirt-Burri N, Scaletta C, Gerber S, Pioletti DP, Applegate LA (2008) Wound-healing gene family expression differences between fetal and foreskin cells used for bioengineered skin substitutes. Artif Organs 32(7):509-518
49. Hogan BL (1996) Bone morphogenetic proteins in development. Curr Opin Genet Dev 6(4):432-438
50. Honda Y, Anada T, Kamakura S, Nakamura M, Sugawara S, Suzuki O (2006) Elevated extracellular calcium stimulates secretion of bone morphogenetic protein 2 by a macrophage cell line. Biochem Biophys Res Commun 345(3):1155-1160
51. Hong JH, Lee GT, Lee JH, Kwon SJ, Park SH, Kim SJ, Kim IY (2009) Effect of bone morphogenetic protein-6 on macrophages. Immunology 128(1 Suppl):e442-e450
52. Horbinski C, Stachowiak EK, Chandrasekaran V, Miuzukoshi E, Higgins D, Stachowiak MK (2002) Bone morphogenetic protein-7 stimulates initial dendritic growth in sympathetic neurons through an intracellular fibroblast growth factor signaling pathway. J Neurochem 80(1):54-63
53. Hubner G, Hu Q, Smola H, Werner S (1996) Strong induction of activin expression after injury suggests an important role of activin in wound repair. Dev Biol 173(2):490-498
54. Hwang EA, Lee HB, Tark KC (2001) Comparison of bone morphogenetic protein receptors expression in the fetal and adult skin. Yonsei Med J 42(6):581-586
55. Ito Y, Sarkar P, Mi Q, Wu N, Bringas P Jr, Liu Y, Reddy S, Maxson R, Deng C, Chai Y (2001) Overexpression of Smad2 reveals its concerted action with Smad4 in regulating TGF-beta-mediated epidermal homeostasis. Dev Biol 236(1):181-194
56. Jeffcoate WJ, Harding KG (2003) Diabetic foot ulcers. Lancet 361(9368):1545-1551. doi: 10.1016/S0140-6736(03)13169-8
57. Kaiser S, Schirmacher P, Philipp A, Protschka M, Moll I, Nicol K, Blessing M (1998) Induction of bone morphogenetic protein-6 in skin wounds. Delayed reepitheliazation and scar formation in BMP-6 overexpressing transgenic mice. J Invest Dermatol 111(6):1145-1152
58. Kingsley DM (1994) The TGF-beta superfamily: new members, new receptors, and new genetic tests of function in different organisms. Genes Dev 8(2):133-146
59. Kirana S, Stratmann B, Prante C, Prohaska W, Koerperich H, Lammers D, Gastens MH, Quast T, Negrean M, Stirban OA, Nandrean SG, Gotting C, Minartz P, Kleesiek K, Tschoepe D (2012) Autologous stem cell therapy in the treatment of limb ischaemia induced chronic tissue ulcers of diabetic foot patients. Int J Clin Pract 66(4):384-393
60. Klopcic B, Maass T, Meyer E, Lehr HA, Metzger D, Chambon P, Mann A, Blessing M (2007) TGF-beta superfamily signaling is essential for tooth and hair morphogenesis and differentiation. Eur J Cell Biol 86(11-12):781-799
61. Knighton DR, Fiegel VD (1989) Macrophage-derived growth factors in wound healing: regulation of growth factor production by the oxygen microenvironment. Am Rev Respir Dis 140(4):1108-1111
62. Kozian DH, Ziche M, Augustin HG (1997) The activin-binding protein follistatin regulates autocrine endothelial cell activity and induces angiogenesis. Lab Invest 76(2):267-276
63. Kwon SJ, Lee GT, Lee JH, Kim WJ, Kim IY (2009) Bone morphogenetic protein-6 induces the expression of inducible nitric oxide synthase in macrophages. Immunology 128(1 Suppl):e758-e765
64. Lamouille S, Mallet C, Feige JJ, Bailly S (2002) Activin receptor-like kinase 1 is implicated in the maturation phase of angiogenesis. Blood 100(13):4495-4501
65. Li G, Cui Y, McIlmurray L, Allen WE, Wang H (2005) rhBMP-2, rhVEGF(165), rhPTN and thrombin-related peptide, TP508 induce chemotaxis of human osteoblasts and microvascular endothelial cells. J Orthop Res 23(3):680-685
66. Lin SY, Morrison JR, Phillips DJ, de Kretser DM (2003) Regulation of ovarian function by the TGF-beta superfamily and follistatin. Reproduction 126(2):133-148
67. Liu D, Wang J, Kinzel B, Mueller M, Mao X, Valdez R, Liu Y, Li E (2007) Dosage-dependent requirement of BMP type II receptor for maintenance of vascular integrity. Blood 110(5):1502-1510
68. Liu ZJ, Velazquez OC (2008) Hyperoxia, endothelial progenitor cell mobilization, and diabetic wound healing. Antioxid Redox Signal 10(11):1869-1882
69. Maeshima K, Maeshima A, Hayashi Y, Kishi S, Kojima I (2004) Crucial role of activin a in tubulogenesis of endothelial cells induced by vascular endothelial growth factor. Endocrinology 145(8):3739-3745
70. Maric I, Poljak L, Zoricic S, Bobinac D, Bosukonda D, Sampath KT, Vukicevic S (2003) Bone morphogenetic protein-7 reduces the severity of colon tissue damage and accelerates the healing of inflammatory bowel disease in rats. J Cell Physiol 196(2):258-264
71. Martinez VG, Hernandez-Lopez C, Valencia J, Hidalgo L, Entrena A, Zapata AG, Vicente A, Sacedon R, Varas A (2010) The canonical BMP signaling pathway is involved in human monocyte-derived dendritic cell maturation. Immunol Cell Biol 89(5):610-618
72. Maruyama K, Asai J, Ii M, Thorne T, Losordo DW, D'Amore PA (2007) Decreased macrophage number and activation lead to reduced lymphatic vessel formation and contribute to impaired diabetic wound healing. Am J Pathol 170(4):1178-1191
73. Massague J (2000) How cells read TGF-beta signals. Nat Rev Mol Cell Biol 1(3):169-178
74. McCarthy SA, Bicknell R (1993) Inhibition of vascular endothelial cell growth by activin-A. J Biol Chem 268(31):23066-23071
75. Mi Q, Riviere B, Clermont G, Steed DL, Vodovotz Y (2007) Agent-based model of inflammation and wound healing: insights into diabetic foot ulcer pathology and the role of transforming growth factor-beta1. Wound Repair Regen 15(5):671-682
76. Midwood KS, Williams LV, Schwarzbauer JE (2004) Tissue repair and the dynamics of the extracellular matrix. Int J Biochem Cell Biol 36(6):1031-1037
77. Moser M, Binder O, Wu Y, Aitsebaomo J, Ren R, Bode C, Bautch VL, Conlon FL, Patterson C (2003) BMPER, a novel endothelial cell precursor-derived protein, antagonizes bone morphogenetic protein signaling and endothelial cell differentiation. Mol Cell Biol 23(16):5664-5679
78. Munz B, Smola H, Engelhardt F, Bleuel K, Brauchle M, Lein I, Evans LW, Huylebroeck D, Balling R, Werner S (1999) Overexpression of activin A in the skin of transgenic mice reveals new activities of activin in epidermal morphogenesis, dermal fibrosis and wound repair. EMBO J 18(19):5205-5215
79. Munz B, Tretter YP, Hertel M, Engelhardt F, Alzheimer C, Werner S (2001) The roles of activins in repair processes of the skin and the brain. Mol Cell Endocrinol 180(1-2):169-177
80. Musso T, Scutera S, Vermi W, Daniele R, Fornaro M, Castagnoli C, Alotto D, Ravanini M, Cambieri I, Salogni L, Elia AR, Giovarelli M, Facchetti F, Girolomoni G, Sozzani S (2008) Activin A induces Langerhans cell differentiation in vitro and in human skin explants. PLoS ONE 3(9):e3271
81. Mustoe T (2004) Understanding chronic wounds: a unifying hypothesis on their pathogenesis and implications for therapy. Am J Surg 187(5A):65S-70S
82. Nagamine K, Furue M, Fukui A, Matsuda A, Hori T, Asashima M (2007) Blood cell and vessel formation following transplantation of activin-treated explants in Xenopus. Biol Pharm Bull 30(10):1856-1859
83. Nathan C (2002) Points of control in inflammation. Nature 420(6917):846-852. doi: 10.1038/nature01320
84. Owens P, Han G, Li AG, Wang XJ (2008) The role of Smads in skin development. J Invest Dermatol 128(4):783-790
85. Pangas SA, Woodruff TK (2000) Activin signal transduction pathways. TEM 11(8):309-314
86. Panopoulou E, Murphy C, Rasmussen H, Bagli E, Rofstad EK, Fotsis T (2005) Activin A suppresses neuroblastoma xenograft tumor growth via antimitotic and antiangiogenic mechanisms. Cancer Res 65(5):1877-1886
87. Pavelock KA, Girard BM, Schutz KC, Braas KM, May V (2007) Bone morphogenetic protein down-regulation of neuronal pituitary adenylate cyclase-activating polypeptide and reciprocal effects on vasoactive intestinal peptide expression. J Neurochem 100(3):603-616
88. Poulaki V, Mitsiades N, Kruse FE, Radetzky S, Iliaki E, Kirchhof B, Joussen AM (2004) Activin a in the regulation of corneal neovascularization and vascular endothelial growth factor expression. Am J Pathol 164(4):1293-1302
89. Raida M, Clement JH, Leek RD, Ameri K, Bicknell R, Niederwieser D, Harris AL (2005) Bone morphogenetic protein 2 (BMP-2) and induction of tumor angiogenesis. J Cancer Res Clin Oncol 131(11):741-750
90. Ren R, Charles PC, Zhang C, Wu Y, Wang H, Patterson C (2007) Gene expression profiles identify a role for cyclooxygenase 2-dependent prostanoid generation in BMP6-induced angiogenic responses. Blood 109(7):2847-2853
91. Roberts AB, Russo A, Felici A, Flanders KC (2003) Smad3: a key player in pathogenetic mechanisms dependent on TGF-beta. Ann NY Acad Sci 995:1-10
92. Robson NC, Phillips DJ, McAlpine T, Shin A, Svobodova S, Toy T, Pillay V, Kirkpatrick N, Zanker D, Wilson K, Helling I, Wei H, Chen W, Cebon J, Maraskovsky E (2008) Activin-A: a novel dendritic cell-derived cytokine that potently attenuates CD40 ligand-specific cytokine and chemokine production. Blood 111(5):2733-2743
93. Rogers LC, Frykberg RG, Armstrong DG, Boulton AJ, Edmonds M, Van GH, Hartemann A, Game F, Jeffcoate W, Jirkovska A, Jude E, Morbach S, Morrison WB, Pinzur M, Pitocco D, Sanders L, Wukich DK, Uccioli L (2011) The Charcot foot in diabetes. J Am Podiatr Med Assoc 101(5):437-446
94. Rothhammer T, Bataille F, Spruss T, Eissner G, Bosserhoff AK (2007) Functional implication of BMP4 expression on angiogenesis in malignant melanoma. Oncogene 26(28):4158-4170
95. Rotzer D, Krampert M, Sulyok S, Braun S, Stark HJ, Boukamp P, Werner S (2006) Id proteins: novel targets of activin action, which regulate epidermal homeostasis. Oncogene 25(14):2070-2081
96. Salogni L, Musso T, Bosisio D, Mirolo M, Jala VR, Haribabu B, Locati M, Sozzani S (2009) Activin A induces dendritic cell migration through the polarized release of CXC chemokine ligands 12 and 14. Blood 113(23):5848-5856
97. Scharpfenecker M, van Dinther M, Liu Z, van Bezooijen RL, Zhao Q, Pukac L, Lowik CW, ten Dijke P (2007) BMP-9 signals via ALK1 and inhibits bFGF-induced endothelial cell proliferation and VEGF-stimulated angiogenesis. J Cell Sci 120(Pt 6):964-972
98. Scutera S, Riboldi E, Daniele R, Elia AR, Fraone T, Castagnoli C, Giovarelli M, Musso T, Sozzani S (2008) Production and function of activin A in human dendritic cells. Eur Cytokine Netw 19(1):60-68
99. Shao ES, Lin L, Yao Y, Bostrom KI (2009) Expression of vascular endothelial growth factor is coordinately regulated by the activin-like kinase receptors 1 and 5 in endothelial cells. Blood 114(10):2197-2206
100. Shi Y, Massague J (2003) Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 113(6):685-700
101. Sieveking DP, Ng MK (2009) Cell therapies for therapeutic angiogenesis: back to the bench. Vasc Med 14(2):153-166
102. Singer AJ, Clark RA (1999) Cutaneous wound healing. N Engl J Med 341(10):738-746
103. Soares R, Balogh G, Guo S, Gartner F, Russo J, Schmitt F (2004) Evidence for the notch signaling pathway on the role of estrogen in angiogenesis. Mol Endocrinol 18(9):2333-2343
104. Soares R, Guo S, Gartner F, Schmitt FC, Russo J (2003) 17 beta -estradiol-mediated vessel assembly and stabilization in tumor angiogenesis requires TGF beta and EGFR crosstalk. Angiogenesis 6(4):271-281
105. Stegenga ME, van der Crabben SN, Dessing MC, Pater JM, van den Pangaart PS, de Vos AF, Tanck MW, Roos D, Sauerwein HP, van der Poll T (2008) Effect of acute hyperglycaemia and/or hyperinsulinaemia on proinflammatory gene expression, cytokine production and neutrophil function in humans. Diabet Med 25(2):157-164
106. Stelnicki EJ, Longaker MT, Holmes D, Vanderwall K, Harrison MR, Largman C, Hoffman WY (1998) Bone morphogenetic protein-2 induces scar formation and skin maturation in the second trimester fetus. Plast Reconstr Surg 101(1):12-19
107. Stoitzner P, Stossel H, Wankell M, Hofer S, Heufler C, Werner S, Romani N (2005) Langerhans cells are strongly reduced in the skin of transgenic mice overexpressing follistatin in the epidermis. Eur J Cell Biol 84(8):733-741
108. Sulyok S, Wankell M, Alzheimer C, Werner S (2004) Activin: an important regulator of wound repair, fibrosis, and neuroprotection. Mol Cell Endocrinol 225(1-2):127-132
109. Suzuki Y, Ohga N, Morishita Y, Hida K, Miyazono K, Watabe T (2010) BMP-9 induces proliferation of multiple types of endothelial cells in vitro and in vivo. J Cell Sci 123(Pt 10):1684-1692
110. Symes AJ, Pitts RL, Conover J, Kos K, Coulombe J (2000) Synergy of activin and ciliary neurotrophic factor signaling pathways in the induction of vasoactive intestinal peptide gene expression. Mol Endocrinol 14(3):429-439
111. ten Dijke P, Hill CS (2004) New insights into TGF-beta-Smad signalling. Trends Biochem Sci 29(5):265-273
112. Thompson TB, Cook RW, Chapman SC, Jardetzky TS, Woodruff TK (2004) Beta A versus beta B: is it merely a matter of expression? Mol Cell Endocrinol 225(1-2):9-17
113. Thompson TB, Lerch TF, Cook RW, Woodruff TK, Jardetzky TS (2005) The structure of the follistatin:activin complex reveals antagonism of both type I and type II receptor binding. Dev Cell 9(4):535-543
114. Tsukazaki T, Chiang TA, Davison AF, Attisano L, Wrana JL (1998) SARA, a FYVE domain protein that recruits Smad2 to the TGFbeta receptor. Cell 95(6):779-791
115. Turns M (2011) The diabetic foot: an overview of assessment and complications. Br J Nurs 20(15):S19-S25
116. Urist MR, Strates BS (1971) Bone morphogenetic protein. J Dent Res 50(6):1392-1406
117. Urness LD, Sorensen LK, Li DY (2000) Arteriovenous malformations in mice lacking activin receptor-like kinase-1. Nat Genet 26(3):328-331
118. Wagner K, Peters M, Scholz A, Benckert C, Ruderisch HS, Wiedenmann B, Rosewicz S (2004) Activin A stimulates vascular endothelial growth factor gene transcription in human hepatocellular carcinoma cells. Gastroenterology 126(7):1828-1843
119. Wang D, Prakash J, Nguyen P, Davis-Dusenbery BN, Hill NS, Layne MD, Hata A, Lagna G (2012) Bone morphogenetic protein signaling in vascular disease: anti-inflammatory action through myocardin-related transcription factor A. J Biol Chem 287(33):28067-28077
120. Wang SY, Tai GX, Zhang PY, Mu DP, Zhang XJ, Liu ZH (2008) Inhibitory effect of activin A on activation of lipopolysaccharide-stimulated mouse macrophage RAW264.7 cells. Cytokine 42(1):85-91
121. Wankell M, Munz B, Hubner G, Hans W, Wolf E, Goppelt A, Werner S (2001) Impaired wound healing in transgenic mice overexpressing the activin antagonist follistatin in the epidermis. EMBO J 20(19):5361-5372
122. Werner S, Alzheimer C (2006) Roles of activin in tissue repair, fibrosis, and inflammatory disease. Cytokine Growth Factor Rev 17(3):157-171
123. Werner S, Beer HD, Mauch C, Luscher B (2001) The Mad1 transcription factor is a novel target of activin and TGF-beta action in keratinocytes: possible role of Mad1 in wound repair and psoriasis. Oncogene 20(51):7494-7504
124. Xu P, Hall AK (2006) The role of activin in neuropeptide induction and pain sensation. Dev Biol 299(2):303-309
125. Xu P, Hall AK (2007) Activin acts with nerve growth factor to regulate calcitonin gene-related peptide mRNA in sensory neurons. Neuroscience 150(3):665-674
126. Xu P, Van Slambrouck C, Berti-Mattera L, Hall AK (2005) Activin induces tactile allodynia and increases calcitonin gene-related peptide after peripheral inflammation. J Neurosci 25(40):9227-9235
127. Yan C, Grimm WA, Garner WL, Qin L, Travis T, Tan N, Han YP (2010) Epithelial to mesenchymal transition in human skin wound healing is induced by tumor necrosis factor-alpha through bone morphogenic protein-2. Am J Pathol 176(5):2247-2258
128. Yang L, Yamasaki K, Shirakata Y, Dai X, Tokumaru S, Yahata Y, Tohyama M, Hanakawa Y, Sayama K, Hashimoto K (2006) Bone morphogenetic protein-2 modulates Wnt and frizzled expression and enhances the canonical pathway of Wnt signaling in normal keratinocytes. J Dermatol Sci 42(2):111-119
129. Zhang C, Wang KZ, Qiang H, Tang YL, Li Q, Li M, Dang XQ (2010) Angiopoiesis and bone regeneration via co-expression of the hVEGF and hBMP genes from an adeno-associated viral vector in vitro and in vivo. Acta Pharmacol Sin 31(7):821-830
130. Zhang F, Qiu T, Wu X, Wan C, Shi W, Wang Y, Chen JG, Wan M, Clemens TL, Cao X (2009) Sustained BMP signaling in osteoblasts stimulates bone formation by promoting angiogenesis and osteoblast differentiation. J Bone Miner Res 24(7):1224-1233
131. Zhang M, Liu NY, Wang XE, Chen YH, Li QL, Lu KR, Sun L, Jia Q, Zhang L, Zhang L (2011) Activin B promotes epithelial wound healing in vivo through RhoA-JNK signaling pathway. PLoS ONE 6(9):e25143
132. Zhou Q, Heinke J, Vargas A, Winnik S, Krauss T, Bode C, Patterson C, Moser M (2007) ERK signaling is a central regulator for BMP-4 dependent capillary sprouting. Cardiovasc Res 76(3):390-399